The Meridian Bioscience Inc. board elected John Rice as an independent director.
Rice is with venture capital firm Triathlon Medical Venture Partners.
Discover more about S&P Global’s offerings
Meridian Bioscience board elects independent director
Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
The Meridian Bioscience Inc. board elected John Rice as an independent director.
Rice is with venture capital firm Triathlon Medical Venture Partners.